To date, most studies have focussed on immunohistochemical findings, although genomic amplification of JUNB with concomitant increased expression, leads to deregulated AP-1 activity in CTCL [138]. Here, JUNB is linked to primary cutaneous T-cell non-Hodgkin lymphoma.